Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 15, 2019

Primary Completion Date

September 27, 2020

Study Completion Date

September 27, 2020

Conditions
Ketamine-Induced Psychotic DisorderSocial CognitionTheory of Mind
Interventions
DRUG

Ketamine

Ketamine is applied with a Graseby 3500 intravenous infusion pump controlled by the STANPUMP software (Steven Shafer, M.D., Anesthesiology Service, PAVAMC 3801 Miranda Ave., Palo Alto, USA). Target plasma levels are 100 ng/ml with an initial bolus administered as a 2 mg/ml solution.

DRUG

Nacl 0.9%

Saline solution will also be applied with the Graseby 3500 intravenous infusion pump controlled by the STANPUMP software (Steven Shafer, M.D., Anesthesiology Service, PAVAMC 3801 Miranda Ave., Palo Alto, USA).

Trial Locations (1)

53127

Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn

All Listed Sponsors
lead

University Hospital, Bonn

OTHER

NCT05320991 - Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers | Biotech Hunter | Biotech Hunter